BR9803933A - Trans-3,4,4a,5,6,10b-hexahidro-2h-nafto [1,2-b]-1,4-oxazinas dissubstituìdas, um processo para sua preparação e composições farmacêuticas que as contêm - Google Patents

Trans-3,4,4a,5,6,10b-hexahidro-2h-nafto [1,2-b]-1,4-oxazinas dissubstituìdas, um processo para sua preparação e composições farmacêuticas que as contêm

Info

Publication number
BR9803933A
BR9803933A BR9803933-4A BR9803933A BR9803933A BR 9803933 A BR9803933 A BR 9803933A BR 9803933 A BR9803933 A BR 9803933A BR 9803933 A BR9803933 A BR 9803933A
Authority
BR
Brazil
Prior art keywords
hexahydro
trans
preparation
oxazins
dissubstituted
Prior art date
Application number
BR9803933-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean-Louis Peglion
Jean-Christophe Harmange
Mark Millan
Francoise Lejeune
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR9803933A publication Critical patent/BR9803933A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9803933-4A 1997-09-01 1998-08-31 Trans-3,4,4a,5,6,10b-hexahidro-2h-nafto [1,2-b]-1,4-oxazinas dissubstituìdas, um processo para sua preparação e composições farmacêuticas que as contêm BR9803933A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710852A FR2767825A1 (fr) 1997-09-01 1997-09-01 Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BR9803933A true BR9803933A (pt) 2001-04-24

Family

ID=9510643

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9803933-4A BR9803933A (pt) 1997-09-01 1998-08-31 Trans-3,4,4a,5,6,10b-hexahidro-2h-nafto [1,2-b]-1,4-oxazinas dissubstituìdas, um processo para sua preparação e composições farmacêuticas que as contêm

Country Status (18)

Country Link
US (1) US6025356A (enExample)
EP (1) EP0899267B1 (enExample)
JP (1) JP4417451B2 (enExample)
CN (1) CN1088064C (enExample)
AT (1) ATE229513T1 (enExample)
AU (1) AU740928C (enExample)
BR (1) BR9803933A (enExample)
CA (1) CA2246482C (enExample)
DE (1) DE69810034T2 (enExample)
DK (1) DK0899267T3 (enExample)
ES (1) ES2189108T3 (enExample)
FR (1) FR2767825A1 (enExample)
HU (1) HU226059B1 (enExample)
NO (1) NO311218B1 (enExample)
NZ (1) NZ331637A (enExample)
PL (1) PL194533B1 (enExample)
PT (1) PT899267E (enExample)
ZA (1) ZA987963B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
CA2496452A1 (en) * 2002-08-30 2004-03-11 Biostratum, Inc. Inhibitors of post-amadori advanced glycation end products
EP1620083A2 (en) * 2003-04-18 2006-02-01 Pharmacia & Upjohn Company LLC Combination therapies
FR2906249B1 (fr) * 2006-09-26 2008-12-19 Servier Lab Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
WO2009156458A1 (en) * 2008-06-27 2009-12-30 H. Lundbeck A/S Novel phenolic and catecholic amines and prodrugs thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
US5486611A (en) * 1989-07-13 1996-01-23 The Upjohn Company Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives
WO1991019719A1 (en) * 1990-06-15 1991-12-26 Whitby Research, Inc. Substituted naphthoxazines useful as dopaminergics

Also Published As

Publication number Publication date
HUP9801951A2 (hu) 2000-02-28
EP0899267A1 (fr) 1999-03-03
CN1222516A (zh) 1999-07-14
US6025356A (en) 2000-02-15
AU740928C (en) 2002-05-16
NO984007L (no) 1999-03-02
JPH11130759A (ja) 1999-05-18
HUP9801951A3 (en) 2000-04-28
NO984007D0 (no) 1998-08-31
NO311218B1 (no) 2001-10-29
DE69810034T2 (de) 2003-08-14
CA2246482C (fr) 2002-11-26
HU226059B1 (en) 2008-04-28
CN1088064C (zh) 2002-07-24
CA2246482A1 (fr) 1999-03-01
DK0899267T3 (da) 2003-03-10
AU740928B2 (en) 2001-11-15
PL194533B1 (pl) 2007-06-29
PT899267E (pt) 2003-04-30
HK1020340A1 (en) 2000-04-14
AU8302498A (en) 1999-03-11
DE69810034D1 (de) 2003-01-23
ATE229513T1 (de) 2002-12-15
PL328285A1 (en) 1999-03-15
EP0899267B1 (fr) 2002-12-11
ES2189108T3 (es) 2003-07-01
HU9801951D0 (en) 1998-11-30
JP4417451B2 (ja) 2010-02-17
NZ331637A (en) 1999-07-29
FR2767825A1 (fr) 1999-02-26
ZA987963B (en) 1999-03-04

Similar Documents

Publication Publication Date Title
BR0112986A (pt) Compostos azabicìclicos, o respectivo preparo e a respectiva utilização como medicamentos, notadamente como antibacteriano
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
PT83508B (pt) Processo para a preparacao de composicoes farmaceuticas de accao prolongada
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
PT96145A (pt) Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
BR9812772A (pt) "compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
BR0309012A (pt) Uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para a preparação de um composto
BR0015147A (pt) Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
PT839041E (pt) Sais de derivados de amidina e de inibidor de ciclooxigenase processo para a sua preparacao sua utilizacao como farmacos e composicoes farmaceuticas contendo os referidos sais
BR9802804A (pt) Compostos benzimidazol, benzoxazol e benzotiazol, processo para sua preparação e composições farmacéuticas contendo os mesmos.
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
BR0110357A (pt) Sais bicìclicos e n-aciclados de aminas imidazo - 3 e imidazo -5
PT1233953E (pt) Novos derivados de benzotiadiazinas processo para a sua preparacao e as composicoes farmaceuticas que os contem
BR9611642A (pt) Compostos composição farmacéutica e processo para a preparação de compostos
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
BR9803933A (pt) Trans-3,4,4a,5,6,10b-hexahidro-2h-nafto [1,2-b]-1,4-oxazinas dissubstituìdas, um processo para sua preparação e composições farmacêuticas que as contêm
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
DK0558416T3 (da) 17-methylenlactonsteroider, deres fremstilling, mellemprodukter dertil, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf
BR0013582A (pt) Agonistas retinóides seletivos para rar
BR9800763A (pt) Novos compostos 2-amino indano, um processo para sua preparação e composições farmacêuticas contendo os mesmos.
BR0300698A (pt) Compostos derivados de quinazolina, um processo para sua preparação e composições farmacêuticas contendo-os

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07D 265/36, C07D 401/06, C07D 409/06, A61K 31/538, A61P 25/16, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/24

Ipc: C07D 265/36 (2007.10), C07D 401/06 (2007.10), C07D

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AOS REQUISITOS DE ATIVIDADE INVENTIVA ( ART. 8 COMBINADO COM ART. 13 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]